RxDoctor Payments Data

Andrew Birkeland, MD

Pediatric Otolaryngology · Palo Alto, CANPI 1700149317

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (53.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Intuitive Surgical at 54.3% of the total. Reporting peaked in 2019 at $4,652 and has fallen 97.0% since, to $141 in 2025. Among pediatric otolaryngology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,411in general payments, 2019–2025

Across 13 payments — averaging $646.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • EMD Serono, Inc.$3K
  • Johnson & Johnson$353
  • Inspire Medical Systems, Inc.$125
  • Sanofi$120
  • Integra Lifesciences Corporation$117
  • plus $44 from 1 others
$170,774in research payments, 2019–2025

Across 1 payment — averaging $170,774 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$171K

What the payments were for

  • Consulting fees$3,08837%
  • Food & beverage$82310%
  • Education$4,50054%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,411 in reported general payments places this provider in the 90th percentile of 66 pediatric otolaryngology providers in California.

See all pediatric otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$133,135
Medicare patients
224
Services billed
611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline32$758
Levothyroxine Sodium14$160
Gabapentin11$111
Chlorhexidine Gluconate14$13

Paid to pharmacies, not to this prescriber.

Other pediatric otolaryngology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →